EW Stock Edwards Lifesciences (EW, $85.66) was a top quarterly gainer, rising +15.12%

GET DAILY SIGNALS

Get AI intraday signals

EW - Edwards Lifesciences Corp

Loading...

Price: $85.66

Daily change: +$0.86 (+1.01%)

Daily volume: 7.3M

3-month price change: +$11.25 (+15.12%)

Capitalization: $49.7B

Industry: Medical/Nursing Services

Edwards Lifesciences (EW, $85.66) was one of top quarterly gainers, jumping +1 to $85.66 per share. A.I.dvisor analyzed 218 stocks in the Medical/Nursing Services Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.

Momentum Indicator for EW turns positive, indicating new upward trend

EW saw its Momentum Indicator move above the 0 level on December 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EW just turned positive on December 23, 2025. Looking at past instances where EW's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EW advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 271 cases where EW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.907) is normal, around the industry mean (63.841). P/E Ratio (37.846) is within average values for comparable stocks, (37.253). EW's Projected Growth (PEG Ratio) (4.861) is very high in comparison to the industry average of (1.634). EW has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (8.621) is also within normal values, averaging (36.935).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.